Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Autoimmune thyroid disease induced by interferon therapy].

M Murakami1, S Kakizaki, H Takayama

  • 1First Department of Internal Medicine, Gunma University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|September 14, 1999
PubMed
Summary

Interferon therapy can trigger autoimmune thyroid disease. This study found a link between the human leukocyte antigen (HLA)-A2 and interferon-alpha-induced thyroid dysfunction in chronic hepatitis C patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The expression of presynaptic t-ACPD receptor in rat cerebellum.

Biochemical and biophysical research communications·1992
Same author

L-leucyl-L-arginine, naltrindole and D-arginine block antinociception elicited by L-arginine in mice with carrageenin-induced hyperalgesia.

British journal of pharmacology·1992
Same author

Detection of locally recurrent colorectal cancer with radiolabeled monoclonal antibody H-15.

Japanese journal of cancer research : Gann·1992
Same author

Studies on the structure and function of subtilisin E by protein engineering.

Annals of the New York Academy of Sciences·1992
Same author

Hepatitis C virus infection in hepatocellular carcinoma. Detection of plus-strand and minus-strand viral RNA.

Cancer·1992
Same author

Delayed appearance of G-protein coupled signal transduction system in developing cerebellar Purkinje cell dendrites.

Neuroscience research·1992

Area of Science:

  • Immunology
  • Endocrinology
  • Hepatology

Context:

  • Interferon therapy is a common treatment for chronic viral hepatitis and certain cancers.
  • Autoimmune phenomena, particularly autoimmune thyroid disease, are known side effects of interferon therapy.
  • Chronic hepatitis C infection is a primary indication for interferon-alpha treatment.

Purpose:

  • To investigate the association between human leukocyte antigen (HLA) types and the development of autoimmune thyroid dysfunction following interferon-alpha therapy.
  • To identify specific genetic predispositions in patients with chronic hepatitis C who experience adverse thyroid events post-treatment.

Summary:

  • A study of 439 patients with chronic hepatitis C found that 3.9% developed symptomatic autoimmune thyroid dysfunction after interferon-alpha therapy.

Related Experiment Videos

  • Analysis revealed a significantly higher incidence of the HLA-A2 antigen in patients who developed thyroid dysfunction compared to the general population in Japan.
  • These findings suggest a specific genetic link between HLA-A2 and interferon-alpha-induced autoimmune thyroid dysfunction in this patient cohort.

    • Impact:

    • Identifies HLA-A2 as a potential risk factor for interferon-induced autoimmune thyroid disease.
    • May inform patient selection and monitoring strategies for interferon therapy in chronic hepatitis C.
    • Contributes to understanding the immunopathogenesis of therapy-induced autoimmune disorders.